Published in Gene Ther on February 01, 2006
RNA and disease. Cell (2009) 7.98
The promises and pitfalls of RNA-interference-based therapeutics. Nature (2009) 7.53
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature (2008) 7.10
miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell (2008) 2.57
Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev (2009) 2.30
Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science (2010) 2.21
A status report on RNAi therapeutics. Silence (2010) 2.18
Lipid-based nanotherapeutics for siRNA delivery. J Intern Med (2010) 2.15
MicroRNAs regulate ocular neovascularization. Mol Ther (2008) 1.89
RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol Med (2009) 1.59
Novel functions for small RNA molecules. Curr Opin Mol Ther (2009) 1.39
Modulating the expression of disease genes with RNA-based therapy. PLoS Genet (2007) 1.38
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest (2007) 1.34
Engineering RNA for targeted siRNA delivery and medical application. Adv Drug Deliv Rev (2010) 1.32
MicroRNAs: key modulators of posttranscriptional gene expression. Gastroenterology (2008) 1.16
Current and emerging therapies for the treatment of age-related macular degeneration. Clin Ophthalmol (2008) 1.05
The Business of RNAi Therapeutics in 2012. Mol Ther Nucleic Acids (2012) 1.01
Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am J Pathol (2007) 1.01
Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model. Proc Natl Acad Sci U S A (2011) 1.01
Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration. J Neuroinflammation (2012) 0.98
Glioma angiogenesis: Towards novel RNA therapeutics. Cell Adh Migr (2009) 0.98
Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase. Jpn J Ophthalmol (2008) 0.96
RNAi Therapeutic Platforms for Lung Diseases. Pharmaceuticals (Basel) (2013) 0.92
The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment. Exp Diabetes Res (2012) 0.91
The treatment of wet age-related macular degeneration. Dtsch Arztebl Int (2009) 0.91
Lentiviral delivery of RNAi for in vivo lineage-specific modulation of gene expression in mouse lung macrophages. Mol Ther (2013) 0.91
Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes. Mol Vis (2008) 0.90
Nanoparticle-mediated gene silencing confers radioprotection to salivary glands in vivo. Mol Ther (2013) 0.90
Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1. Prostaglandins Other Lipid Mediat (2007) 0.89
Non-viral siRNA delivery into the mouse retina in vivo. BMC Ophthalmol (2010) 0.88
Age-related macular degeneration and the other double helix. The Cogan Lecture. Invest Ophthalmol Vis Sci (2011) 0.88
Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization. Invest Ophthalmol Vis Sci (2012) 0.88
Novel developments in angiogenesis cancer therapy. Curr Oncol (2009) 0.86
In vivo imaging of RNA interference. J Nucl Med (2010) 0.85
Targeting Neovascularization in Ischemic Retinopathy: Recent Advances. Expert Rev Ophthalmol (2013) 0.84
In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma. Mol Ther (2013) 0.83
Inhibition of connective tissue growth factor by small interfering ribonucleic acid prevents increase in extracellular matrix molecules in a rodent model of diabetic retinopathy. Mol Vis (2012) 0.83
Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy. Br J Pharmacol (2013) 0.83
Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy. J Ophthalmol (2015) 0.83
Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis. Recent Pat Biomed Eng (2012) 0.82
Dendrimers for siRNA Delivery. Pharmaceuticals (Basel) (2013) 0.82
Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization. Mol Vis (2010) 0.81
Bevasiranib for the treatment of wet, age-related macular degeneration. Ophthalmol Eye Dis (2010) 0.81
Age-related macular degeneration: experimental and emerging treatments. Clin Ophthalmol (2009) 0.80
Targeted suppression of HO-2 gene expression impairs the innate anti-inflammatory and repair responses of the cornea to injury. Mol Vis (2011) 0.80
RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Adv Drug Deliv Rev (2011) 0.80
RNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases. Mol Med (2009) 0.79
SiRNA targeting EGFR effectively prevents posterior capsular opacification after cataract surgery. Mol Vis (2011) 0.78
PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy. Oligonucleotides (2011) 0.76
Validation of RNAi Silencing Efficiency Using Gene Array Data shows 18.5% Failure Rate across 429 Independent Experiments. Mol Ther Nucleic Acids (2016) 0.75
Multimodality imaging of RNA interference. Curr Med Chem (2013) 0.75
Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis. Immunology (2016) 0.75
Coupling Aptamers to Short Interfering RNAs as Therapeutics. Pharmaceuticals (Basel) (2011) 0.75
Association of toll-like receptor 3 polymorphism rs3775291 with age-related macular degeneration: a systematic review and meta-analysis. Sci Rep (2016) 0.75
[siRNA in macular degeneration]. Ophthalmologe (2010) 0.75
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci (1999) 18.57
Representing information in patient reports using natural language processing and the extensible markup language. J Am Med Inform Assoc (1999) 6.76
Are Latinos less satisfied with communication by health care providers? J Gen Intern Med (1999) 5.26
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood (2001) 5.17
The PX domains of p47phox and p40phox bind to lipid products of PI(3)K. Nat Cell Biol (2001) 4.64
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum (1998) 4.37
Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc (1997) 3.69
The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis (1985) 3.66
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol (1989) 3.58
Choice making to promote adaptive behavior for students with emotional and behavioral challenges. J Appl Behav Anal (1994) 3.50
Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol (2001) 3.50
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood (1999) 3.46
Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A (1997) 3.42
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol (2000) 3.26
Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell (2001) 3.10
Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science (2001) 2.98
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology (2012) 2.78
The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood (2001) 2.77
Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol (1997) 2.73
Direct binding of G-protein betagamma complex to voltage-dependent calcium channels. Nature (1997) 2.60
p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci U S A (1996) 2.58
Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann Surg (1981) 2.53
Molecular subtyping of Treponema pallidum subspecies pallidum. Sex Transm Dis (1998) 2.44
Evaluating the UMLS as a source of lexical knowledge for medical language processing. Proc AMIA Symp (2001) 2.41
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol (2000) 2.41
VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 2.38
Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke (1998) 2.35
Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase. Proc Natl Acad Sci U S A (1993) 2.34
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol (1998) 2.33
Social networks in adult life and a preliminary examination of the convoy model. J Gerontol (1987) 2.31
Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol (1988) 2.28
Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest (2000) 2.26
Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol (1994) 2.25
Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc Natl Acad Sci U S A (2001) 2.25
Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO J (1997) 2.23
Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci (1999) 2.23
Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol (1999) 2.16
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity (2001) 2.16
DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida albicans. J Biol Chem (2001) 2.14
Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2007) 2.13
Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science (1995) 2.12
Development of the human corpus callosum during childhood and adolescence: a longitudinal MRI study. Prog Neuropsychopharmacol Biol Psychiatry (1999) 2.10
The impact of boreal forest fire on climate warming. Science (2006) 2.08
Efficient high-frequency body coil for high-field MRI. Magn Reson Med (2004) 2.07
Posterior paravertebral ossification causing cervical myelopathy. A report of eighteen cases. J Bone Joint Surg Am (1967) 2.07
Prediction of linear B-cell epitopes using amino acid pair antigenicity scale. Amino Acids (2007) 2.06
Upregulation of 78-kDa glucose-regulated protein in macrophages in peripheral joints of active ankylosing spondylitis. Scand J Rheumatol (2008) 2.06
Sub-maximal and maximal Yo-Yo intermittent endurance test level 2: heart rate response, reproducibility and application to elite soccer. Eur J Appl Physiol (2010) 2.05
Dhh1p, a putative RNA helicase, associates with the general transcription factors Pop2p and Ccr4p from Saccharomyces cerevisiae. Genetics (1998) 2.02
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol (1992) 2.01
Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J Biol Chem (1999) 2.00
Subretinal fluid stimulation of retinal pigment epithelial cell migration and proliferation is dependent on certain features of the detachment or its treatment. Arch Ophthalmol (1989) 1.98
Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J Biol Chem (1993) 1.98
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet (2001) 1.97
Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem (1998) 1.95
Suicide and social change in China. Cult Med Psychiatry (1999) 1.94
Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol (2001) 1.94
Validation of a serologic test for the diagnosis of Helicobacter pylori infection and the immune response to urease and CagA in children. Am J Gastroenterol (1998) 1.93
Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. J Virol (1993) 1.90
Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol (1997) 1.90
Microglia in degenerative neurological disease. Glia (1993) 1.89
Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis (2001) 1.88
Effects of insulin on steady state kinetics of GLUT4 subcellular distribution in rat adipocytes. Evidence of constitutive GLUT4 recycling. J Biol Chem (1992) 1.86
Molecular subtyping of Treponema pallidum in an Arizona County with increasing syphilis morbidity: use of specimens from ulcers and blood. J Infect Dis (2001) 1.86
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene (2009) 1.85
Use of the stomach as an esophageal substitute. Ann Surg (1978) 1.84
Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci (1998) 1.83
Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis (2006) 1.82
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema. Br J Ophthalmol (2009) 1.82
PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis. Cell Death Differ (2009) 1.81
Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry (1995) 1.80
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum (2000) 1.79
Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem (2001) 1.78
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol (1995) 1.77
Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort. Arthritis Rheum (2007) 1.77
An intramolecular quadruplex of (GGA)(4) triplet repeat DNA with a G:G:G:G tetrad and a G(:A):G(:A):G(:A):G heptad, and its dimeric interaction. J Mol Biol (2001) 1.76
Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett (2001) 1.75
Immune system response in Alzheimer's disease. Can J Neurol Sci (1989) 1.75
Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J Immunol (2000) 1.74
Measurement and analysis of brain deformation during neurosurgery. IEEE Trans Med Imaging (2003) 1.73
Flagellation of Pseudomonas putida and analysis of its motile behavior. J Bacteriol (1989) 1.71
Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin Radiol (2009) 1.70
Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis (2001) 1.69
Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol (2001) 1.69
Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci (1998) 1.68
HIV-related sexual behaviour among migrants and non-migrants in a rural area of China: role of rural-to-urban migration. Public Health (2006) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Childhood-onset schizophrenia: progressive brain changes during adolescence. Biol Psychiatry (1999) 1.66
Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett (1989) 1.66
Non-traumatic acute paraplegia associated with cervical disc herniation: a case report. Surg Neurol (1999) 1.66
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood (2001) 1.66
ICRP Publication 111 - Application of the Commission's recommendations to the protection of people living in long-term contaminated areas after a nuclear accident or a radiation emergency. Ann ICRP (2009) 1.63
Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J Mol Cell Cardiol (2001) 1.63
Bioterrorism preparedness and response: use of information technologies and decision support systems. Evid Rep Technol Assess (Summ) (2002) 1.61
A G1 cyclin is necessary for maintenance of filamentous growth in Candida albicans. Mol Cell Biol (1999) 1.61